Supplementary Agreement Chinese

The statement stated that the signing of the additional agreement was a continuation of the important consensus recently reached by the two countries. Hu Wei (1st R), business manager of the Chinese Embassy in Sri Lanka, and Vasudeva Nanayakkara (2nd R), Sri Lankan Minister of Water Supply, pose for a photo after signing an additional agreement on 14 October 2020 in Colombo, the capital of Sri Lanka. Sri Lanka and China signed a complementary agreement on Wednesday on a water research and cooperation agreement to provide safe drinking water to several parts of the island state, the Chinese Embassy in Sri Lanka said. (Xinhua/Tang Lu) COLOMBO, October 14 (Xinhua) – Sri Lanka and China on Wednesday signed a complementary agreement on water research and cooperation to provide safe drinking water to several parts of the island state, according to a statement from the Chinese Embassy in Sri Lanka. In March 2015, the slack between Sri Lanka and China was coloured to fight chronic kidney disease of unknown etiology (CKDu) and to provide drinking water to the pre-existing CKDu regions of Sri Lanka. As part of the MoU, a state-of-the-art water technology research and demonstration centre (JRDC) was recently established on the Peradeniya University campus in the central highlands of Kandy, while the Chinese Academy of Sciences will continue to fund JRDC cooperation over the next five years. In addition, three groundwater purification demonstration projects and more than 20 rainwater catchment equipment have been built in CKDu-affected areas in Sri Lanka to provide quality drinking water to more than 4,000 villagers and 1,300 primary school students, he said. “In addition, over the past five years, 66 water and health professionals have participated in CAS training programs and 53 Sri Lankan students (including 19 PhD students) are currently studying at the University of the Chinese Academy of Sciences (UCAS),” she added. Enditem.

This entry was posted in Uncategorized. Bookmark the permalink.

Comments are closed.